{"url_path":"/sec/idxg/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1054102/0001493152-26-022508-index.html","accession_number":"0001493152-26-022508","cik":"0001054102","ticker":"IDXG","issuer_name":"INTERPACE BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1054102/0001493152-26-022508-index.html","primary_entity_key":"0001054102","primary_entity_name":"INTERPACE BIOSCIENCES, INC."},"word_count":433,"has_tables":true,"body_markdown":"** **\n\n**Item\n6. Exhibits**\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n \n \n \n\n3.1\n \n[Conformed version of Certificate of Incorporation of Interpace Biosciences, Inc., as amended most recently by the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock, effective October 11, 2024, incorporated by reference to Exhibit 3.1 of the Company’s Quarterly Report on Form 10-Q, filed with the SEC on November 8, 2024.](https://www.sec.gov/Archives/edgar/data/1054102/000149315224044265/ex3-1.htm)\n\n \n \n \n\n3.2\n \n[Amended and Restated Bylaws of Interpace Biosciences, Inc., incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K, filed with the SEC on November 14, 2019.](https://www.sec.gov/Archives/edgar/data/1054102/000149315219017468/ex3-2.htm)\n\n \n \n \n\n31.1*\n \n[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm)\n\n \n \n \n\n31.2*\n \n[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm)\n\n \n \n \n\n32.1+\n \n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n \n \n \n\n32.2+\n \n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-2.htm)\n\n \n \n \n\n101.INS\n \nInline\nXBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded\nwithin the Inline XBRL document.\n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document.\n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document.\n\n101.PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document.\n\n104\n \nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101).\n\n \n\n \n*\nFiled\nHerewith.\n\n \n \n \n\n \n+\nExhibits\n32.1 and 32.2 are being furnished herewith and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange\nAct or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference to any\nregistration statement or other document filed under the Securities Act or the Exchange Act, except as otherwise stated in any such\nfiling.\n\n \n\n23\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, thereunto duly authorized.\n\n \n\nDate:\nMay 12, 2026\nInterpace\nBiosciences, Inc.\n\n \n(Registrant)\n\n \n \n\n \n*/s/\nThomas W. Burnell*\n\n \nThomas\nW. Burnell\n\n \nPresident\nand Chief Executive Officer\n\n \n(Principal\nExecutive Officer)\n\n \n \n\nDate:\nMay 12, 2026\n*/s/\nChristopher McCarthy*\n\n \n\nChristopher\nMcCarthy\n\nChief\nFinancial Officer and Chief Operating Officer\n\n \n(Principal\nFinancial Officer)\n\n \n\n24\n\n** **\n\n** **"}